Intuitive Surgical (NASDAQ:ISRG) Given New $654.00 Price Target at Wells Fargo & Company

Intuitive Surgical (NASDAQ:ISRG) had its price target raised by Wells Fargo & Company from $600.00 to $654.00 in a research note issued to investors on Friday,MarketScreener reports. The brokerage currently has an overweight rating on the medical equipment provider’s stock.

Other equities analysts also recently issued reports about the stock. The Goldman Sachs Group upped their price objective on shares of Intuitive Surgical from $567.00 to $621.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. Daiwa Capital Markets increased their price target on shares of Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a report on Friday, October 24th. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Mizuho set a $575.00 price target on Intuitive Surgical in a report on Wednesday, October 22nd. Finally, Evercore ISI upped their price objective on Intuitive Surgical from $450.00 to $540.00 in a report on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $608.79.

Intuitive Surgical Stock Down 0.9%

Shares of NASDAQ ISRG opened at $542.32 on Friday. The business’s 50 day moving average price is $529.62 and its two-hundred day moving average price is $506.00. The company has a market cap of $194.41 billion, a PE ratio of 71.74, a price-to-earnings-growth ratio of 5.03 and a beta of 1.68. Intuitive Surgical has a twelve month low of $425.00 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same period in the previous year, the company posted $1.84 EPS. The firm’s revenue for the quarter was up 22.9% compared to the same quarter last year. As a group, research analysts anticipate that Intuitive Surgical will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 104 shares of the firm’s stock in a transaction dated Wednesday, December 10th. The shares were sold at an average price of $559.90, for a total value of $58,229.60. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Craig H. Barratt sold 750 shares of the business’s stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $435,000.00. The SEC filing for this sale provides additional information. Insiders have sold a total of 109,043 shares of company stock valued at $60,816,225 over the last three months. 0.70% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of ISRG. Norway Savings Bank increased its holdings in shares of Intuitive Surgical by 53.4% in the 2nd quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock worth $1,420,000 after buying an additional 910 shares during the last quarter. Trust Co. of Oklahoma bought a new position in Intuitive Surgical in the second quarter valued at $363,000. IronOak Wealth LLC. purchased a new stake in Intuitive Surgical during the second quarter valued at about $1,099,000. Eastover Investment Advisors LLC lifted its stake in Intuitive Surgical by 204.8% during the second quarter. Eastover Investment Advisors LLC now owns 13,163 shares of the medical equipment provider’s stock worth $7,153,000 after purchasing an additional 8,844 shares during the last quarter. Finally, Amalgamated Bank boosted its holdings in shares of Intuitive Surgical by 2.2% in the 2nd quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock worth $44,311,000 after purchasing an additional 1,772 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.